Is oocyte maturation rate associated with the dose of triptorelin used for triggering final oocyte maturation in high-risk for severe OHSS patients, undergoing ovarian stimulation.

被引：0
|
作者：
Lainas, T. G. [1 ]
Lainas, G. [1 ]
Sfontouris, I. [1 ]
Venetis, C. [2 ]
Bosdou, J. [3 ]
Chatzimeletiou, A. [3 ]
Tarlatzis, B. [3 ]
Grimbizis, G. [3 ]
Kolibianakis, E. [3 ]
机构：
[1] Eugonia, Unit Assisted Reprod, Athens, Greece
[2] Univ New South Wales, Sch Womens & Childrens Hlth, UNSW Med, Sydney, NSW, Australia
[3] Aristotle Univ Thessaloniki, Sch Med, Human Reprod Unit, Dept Obstet & Gynecol 1, Thessaloniki, Greece
来源：
HUMAN REPRODUCTION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-606
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [41] A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial
    Abbara, Ali
    Clarke, Sophie
    Islam, Rumana
    Prague, Julia K.
    Comninos, Alexander N.
    Narayanaswamy, Shakunthala
    Papadopoulou, Deborah
    Roberts, Rachel
    Izzi-Engbeaya, Chioma
    Ratnasabapathy, Risheka
    Nesbitt, Alexander
    Vimalesvaran, Sunitha
    Salim, Rehan
    Lavery, Stuart A.
    Bloom, Stephen R.
    Huson, Les
    Trew, Geoffrey H.
    Dhillo, Waljit S.
    HUMAN REPRODUCTION, 2017, 32 (09) : 1915 - 1924
  • [42] Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience
    Jhansi Reddy
    Volkan Turan
    Giuliano Bedoschi
    Fred Moy
    Kutluk Oktay
    Journal of Assisted Reproduction and Genetics, 2014, 31 : 927 - 932
  • [43] Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience
    Reddy, Jhansi
    Turan, Volkan
    Bedoschi, Giuliano
    Moy, Fred
    Oktay, Kutluk
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2014, 31 (07) : 927 - 932
  • [44] Prevention of ovarian hyperstimulation syndrome (OHSS) with the use of gonadotropin releasing hormone (GnRH) agonist to trigger final oocyte maturation after cotreatment with GnRH antagonist in patients with polycystic ovarian syndrome (PCOS) or previous high response undergoing IVF treatment - A prospective randomized clinical trial.
    Engmann, L
    Diluigi, A
    Schmidt, D
    Nulsen, J
    Maier, D
    Benadiva, C
    FERTILITY AND STERILITY, 2005, 84 : S96 - S96
  • [45] The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
    Engmann, Lawrence
    DiLuigi, Andrea
    Schmidt, David
    Nulsen, John
    Maier, Donald
    Benadiva, Claudio
    FERTILITY AND STERILITY, 2008, 89 (01) : 84 - 91
  • [46] High embryo yield (and not oocyte yield) despite low ovarian stimulation dose correlates with cumulative livebirth rate in normal-high responders undergoing IVF/ICSI
    Datta, A. K.
    Raghava, R.
    Campbell, S.
    Nargund, G.
    HUMAN REPRODUCTION, 2023, 38
  • [47] Pregnancy and Birth After GnRH Agonist Treatment for Induction of Final Oocyte Maturation in a Woman Undergoing Ovarian Stimulation for ICSI, Using a GnRH Antagonist (Orgalutran/Antagon) to Prevent a Premature LH Surge: A Case Report
    Diederick de Jong
    Eric G. van Hooren
    Nicholas S. Macklon
    Bernadette M. J. L. Mannaerts
    Bart C. J. M. Fauser
    Journal of Assisted Reproduction and Genetics, 2001, 18 : 30 - 33
  • [48] DOES THE DAY OF FINAL OOCYTE MATURATION INJECTION PREDICT OUTCOMES IN COUPLES UNDERGOING IN VITRO FERTILIZATION/INTRACYTO-PLASMIC SPERM INJECTION - AN ANALYSIS BASED ON AGE AND INDIVIDUAL CONTROLLED OVARIAN STIMULATION PROTOCOL.
    Eapen, Abey
    Sparks, Amy E.
    Zhou, Yunshu
    Summers, Karen M.
    Ten Eyck, Patrick
    Duran, Eyup Hakan
    FERTILITY AND STERILITY, 2019, 112 (03) : E161 - E161
  • [49] Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (orgalutran/antagon) to prevent a premature LH surge: A case report
    De Jong, D
    Van Hooren, EG
    Macklon, NS
    Mannaerts, BMJL
    Fauser, BCJM
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2001, 18 (01) : 30 - 33
  • [50] Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment
    Beckers, NGM
    Macklon, NS
    Eijkemans, MJ
    Ludwig, M
    Felberbaum, RE
    Diedrich, K
    Bustion, S
    Loumaye, E
    Fauser, BCJM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09): : 4186 - 4192
12345